# Safety Study of AMG 557 in Subjects With Lupus Arthritis

> **NCT01683695** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 20 (actual)

## Conditions studied

- Lupus Arthritis, Systemic Lupus Erythematosus

## Interventions

- **DRUG:** AMG 557
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT01683695
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683695, "Safety Study of AMG 557 in Subjects With Lupus Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01683695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*